- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05700019
Effects of 'Pinkwashed' Alcohol Ads in an Online RCT
November 9, 2023 updated by: University of North Carolina, Chapel Hill
The primary objective of this study is to examine how exposure to "pinkwashed" alcohol advertisements (i.e., ads that associate the company with breast cancer awareness or charities) affects consumers' perceptions that alcohol increases the risk of breast cancer.
The investigators will randomize participants to view 3 'pinkwashed' social media advertisements for alcohol or 3 control advertisements for alcohol (i.e., 'de-pinked' standard alcohol advertisements that match the intervention advertisements on overall design but do not mention breast cancer).
Each participant will view the 3 advertisements for their arm (presented in random order) and respond to survey questions programmed in Qualtrics.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
602
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Chapel Hill, North Carolina, United States, 27516
- UNC - Chapel Hill
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- 18 years old or older
Exclusion Criteria:
- Less than 18 years old
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Control - Standard Advertisements
In the control condition, participants will view 3 advertisements for alcohol (shown in random order) that do not mention breast cancer awareness or charities.
Advertisements will be real social media posts used by alcohol companies, modified only to remove dates, likes/comments, and references to specific geographic locations.
|
Real advertisements from the same alcoholic beverage companies' social media accounts that do not contain messaging or other features associated with breast cancer awareness or research.
|
Experimental: Pinkwashed Advertisements
In the pinkwashed condition, participants will view 3 advertisements for alcohol (shown in random order) that associate the alcohol company with breast cancer awareness or research (e.g., indicate that a portion of sales will be directed to a breast cancer-related foundation).
Advertisements will be real social media posts used by alcohol companies, modified only to remove dates, likes/comments, and references to specific geographic locations.
|
Real advertisements from alcoholic beverage companies' social media accounts that contain messaging or other features that associate the alcohol company with breast cancer awareness or research.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Breast cancer risk perceptions
Time Frame: During ~20 minute online survey
|
This outcome will be measured with an adapted item from the HINTS (2020) survey.
The question is worded " In your opinion, how much does drinking [wine/beer/liquor] affect the risk of developing each of the following outcomes... Breast cancer."
Response options are on a five point likert-type scale ranging from "Decreases risk a lot" (=1) to "Increases risk a lot " (=5).
Participants will be asked to respond to this item three times, once for each type of alcoholic beverage presented (wine, beer, liquor).
Scores from the three items will then be averaged for analyses.
Higher scores indicate higher risk perceptions.
|
During ~20 minute online survey
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Perceived product healthfulness
Time Frame: During ~20 minute online survey
|
This outcome will be measured with one item adapted from Bollard et al (2016).
The question will read: "How healthy or unhealthy do you think it is to drink this product?"
and will be measured with a 5-point likert-type response scale ranging from "Very unhealthy" (1) to "Very healthy"(5).
Higher scores indicate greater healthfulness perceptions.
|
During ~20 minute online survey
|
Perceived social responsibility of brand
Time Frame: During ~20 minute online survey
|
This outcome will be measured with one item adapted from Nan & Heo (2017).
The question will read: "How socially responsible do you think the company that makes this product is?" and will be measured with a 5-point likert-type response scale ranging from "Very socially irresponsible" (1) to "Very socially responsible" (5).
Higher scores indicate perceptions of social responsibility.
|
During ~20 minute online survey
|
Favorable attitudes toward brand
Time Frame: During ~20 minute online survey
|
This outcome will be measured with one item adapted from Nan & Heo (2017).
The question will read: "How do you feel about the company that makes this product?"
and will be measured with a 5-point likert-type response scale ranging from "Dislike it a lot" (1) to "Like it a lot" (5).
Higher scores indicate more favorable attitudes.
|
During ~20 minute online survey
|
Purchase intentions
Time Frame: During ~20 minute online survey
|
This outcome will be measured with one item adapted from Hall et al (2020).
The question will display all three advertisements that the participant was exposed to (either pinkwashed or control).
It will then query: "How likely would you be to buy any of these products in the next 4 weeks, if they were available?"
and will be measured with a 5-point likert-type response scale ranging from "Not at all likely" (1) to "Extremely likely" (5).
Higher scores indicate greater purchase intentions.
|
During ~20 minute online survey
|
Perceived misleadingness of ads
Time Frame: During ~20 minute online survey
|
Measure of how misleading a participant perceives the advertisement.
Assessed with 1 item adapted from Hall et al. 2020
|
During ~20 minute online survey
|
Support for breast cancer warnings
Time Frame: During ~20 minute online survey
|
Measure of participant support of including breast cancer warning labels on alcoholic beverage products.
Assessed with 1 item adapted from Hall et al. 2018
|
During ~20 minute online survey
|
Stomach cancer risk perceptions
Time Frame: During ~20 minute online survey
|
This outcome will be measured with an adapted item from the HINTS (2020) survey.
The question is worded " In your opinion, how much does drinking [wine/beer/liquor] affect the risk of developing each of the following outcomes... Stomach cancer."
Response options are on a five point likert-type scale ranging from "Decreases risk a lot" (=1) to "Increases risk a lot " (=5).
Participants will be asked to respond to this item three times, once for each type of alcoholic beverage presented (wine, beer, liquor).
Scores from the three items will then be averaged for analyses.
Higher scores indicate higher risk perceptions.
|
During ~20 minute online survey
|
Mouth and throat cancer risk perceptions
Time Frame: During ~20 minute online survey
|
This outcome will be measured with an adapted item from the HINTS (2020) survey.
The question is worded " In your opinion, how much does drinking [wine/beer/liquor] affect the risk of developing each of the following outcomes... Mouth and throat cancer."
Response options are on a five point likert-type scale ranging from "Decreases risk a lot" (=1) to "Increases risk a lot " (=5).
Participants will be asked to respond to this item three times, once for each type of alcoholic beverage presented (wine, beer, liquor).
Scores from the three items will then be averaged for analyses.
Higher scores indicate higher risk perceptions.
|
During ~20 minute online survey
|
Liver cancer risk perceptions
Time Frame: During ~20 minute online survey
|
This outcome will be measured with an adapted item from the HINTS (2020) survey.
The question is worded " In your opinion, how much does drinking [wine/beer/liquor] affect the risk of developing each of the following outcomes... Liver cancer."
Response options are on a five point likert-type scale ranging from "Decreases risk a lot" (=1) to "Increases risk a lot " (=5).
Participants will be asked to respond to this item three times, once for each type of alcoholic beverage presented (wine, beer, liquor).
Scores from the three items will then be averaged for analyses.
Higher scores indicate higher risk perceptions.
|
During ~20 minute online survey
|
Liver disease risk perceptions
Time Frame: During ~20 minute online survey
|
This outcome will be measured with an adapted item from the HINTS (2020) survey.
The question is worded " In your opinion, how much does drinking [wine/beer/liquor] affect the risk of developing each of the following outcomes... Liver disease."
Response options are on a five point likert-type scale ranging from "Decreases risk a lot" (=1) to "Increases risk a lot " (=5).
Participants will be asked to respond to this item three times, once for each type of alcoholic beverage presented (wine, beer, liquor).
Scores from the three items will then be averaged for analyses.
Higher scores indicate higher risk perceptions.
|
During ~20 minute online survey
|
Hypertension risk perceptions
Time Frame: During ~20 minute online survey
|
This outcome will be measured with an adapted item from the HINTS (2020) survey.
The question is worded " In your opinion, how much does drinking [wine/beer/liquor] affect the risk of developing each of the following outcomes...Hypertension."
Response options are on a five point likert-type scale ranging from "Decreases risk a lot" (=1) to "Increases risk a lot " (=5).
Participants will be asked to respond to this item three times, once for each type of alcoholic beverage presented (wine, beer, liquor).
Scores from the three items will then be averaged for analyses.
Higher scores indicate higher risk perceptions.
|
During ~20 minute online survey
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Marissa G Hall, PhD, UNC-Chapel Hill
- Principal Investigator: Anna H Grummon, PhD, Stanford Univeristy
- Principal Investigator: Kurt Ribsl, PhD, UNC-Chapel Hill
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Hall MG, Lazard AJ, Grummon AH, Mendel JR, Taillie LS. The impact of front-of-package claims, fruit images, and health warnings on consumers' perceptions of sugar-sweetened fruit drinks: Three randomized experiments. Prev Med. 2020 Mar;132:105998. doi: 10.1016/j.ypmed.2020.105998. Epub 2020 Jan 23.
- Nan X, Heo K. Consumer Responses to Corporate Social Responsibility (CSR) Initiatives: Examining the Role of Brand-Cause Fit in Cause-Related Marketing. Journal of Advertising. 2007;36(2):63-74. doi:10.2753/JOA0091-3367360204
- Bollard T, Maubach N, Walker N, Ni Mhurchu C. Effects of plain packaging, warning labels, and taxes on young people's predicted sugar-sweetened beverage preferences: an experimental study. Int J Behav Nutr Phys Act. 2016 Sep 1;13(1):95. doi: 10.1186/s12966-016-0421-7.
- Hall MG, Marteau TM, Sunstein CR, Ribisl KM, Noar SM, Orlan EN, Brewer NT. Public support for pictorial warnings on cigarette packs: an experimental study of US smokers. J Behav Med. 2018 Jun;41(3):398-405. doi: 10.1007/s10865-018-9910-2. Epub 2018 Feb 6.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 11, 2023
Primary Completion (Actual)
January 19, 2023
Study Completion (Actual)
January 19, 2023
Study Registration Dates
First Submitted
January 17, 2023
First Submitted That Met QC Criteria
January 17, 2023
First Posted (Actual)
January 26, 2023
Study Record Updates
Last Update Posted (Estimated)
November 13, 2023
Last Update Submitted That Met QC Criteria
November 9, 2023
Last Verified
January 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- 20-2338
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
The investigators will share our deidentified individual participant data, as well as our statistical analysis plan and analytic code on Open Science Framework (OSF), a publicly available data repository.
IPD Sharing Time Frame
The deidentified dataset, SAP, and analytic code will be posted to OSF within 6 months of results publication.
Materials will be available for 7 years after initial posting.
IPD Sharing Access Criteria
There will be no access criteria; information will posted on a publicly available repository.
IPD Sharing Supporting Information Type
- SAP
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
University of Michigan Rogel Cancer CenterRecruitingCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterHyundai Hope On WheelsRecruitingCancer | Pediatric Cancer | Survivorship | Cancer MetastaticUnited States
-
Vanderbilt-Ingram Cancer CenterNational Institutes of Health (NIH)Active, not recruitingAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
MiRXES Pte LtdRecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Prostate Cancer | Thoracic Cancer | Liver CancerSingapore
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedStage I Breast Cancer | Stage I Uterine Corpus Cancer | Stage II Uterine Corpus Cancer | Stage III Uterine Corpus Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage... and other conditionsUnited States
-
Massachusetts General HospitalNational Comprehensive Cancer NetworkCompletedGastric Cancer | Pancreatic Cancer | Esophageal Cancer | Rectal Cancer | Colon Cancer | Hepatobiliary CancerUnited States
-
Johns Hopkins UniversityNational Cancer Institute (NCI); National Institute on Minority Health and...Enrolling by invitationCancer | Advanced Cancer | End Stage Cancer | MalignancyUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
University of California, San FranciscoBristol-Myers Squibb; PfizerTerminatedStage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Metastatic Colorectal Adenocarcinoma | Metastatic Colon Adenocarcinoma | Metastatic Rectal Adenocarcinoma | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Stage IV Colon Cancer | Stage IV Rectal... and other conditionsUnited States
Clinical Trials on Control - Standard Advertisements
-
Oregon Health and Science UniversityCompletedUrinary IncontinenceUnited States
-
Wake Forest University Health SciencesNational Institute on Drug Abuse (NIDA); University of North Carolina, Chapel... and other collaboratorsCompleted
-
University of California, IrvineUniversity of California, Los Angeles; City University of Hong KongWithdrawn
-
University of TorontoCanadian Institutes of Health Research (CIHR)Completed
-
Takeshi MorimotoUniversity of the RyukyusActive, not recruitingCoronary Artery Disease | Hypertension | Type 2 Diabetes | DyslipidemiaJapan
-
Yonsei UniversityNot yet recruitingHypertension | Chronic Kidney Diseases | DyslipidemiasKorea, Republic of
-
University of UtahJohns Hopkins University; Arizona State University; National Multiple Sclerosis...CompletedMultiple Sclerosis | Vertigo | Dizziness | Falls InjuryUnited States
-
HealthpointCompleted
-
Pamukkale UniversityRecruitingRotator Cuff TearsTurkey
-
M.D. Anderson Cancer CenterRecruitingGastrostomy | GastroEsophageal Cancer | GastricUnited States, Japan, Korea, Democratic People's Republic of